Executive Clinical Snapshot
Prof. Dong Zhou, MD, PhD, is the Director of the Department of Neurology at West China Hospital, Sichuan University, and the President of the China Association Against Epilepsy (CAAE). Widely recognized as one of the world's most eminent clinical neurologists and epileptologists, Prof. Zhou was honored with the prestigious Ambassador for Epilepsy Award by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). His clinical leadership has transformed the management of Drug-Resistant Epilepsy (DRE) through multi-modal presurgical mapping, stereoelectroencephalography (SEEG), neuropharmacogenomics, and targeted neuromodulation, while advancing comprehensive diagnostics for complex cerebrovascular and neuroimmunological disorders.
Academic Leadership & International Standing
- President, China Association Against Epilepsy (CAAE).
- Director, Department of Neurology, West China Hospital, Sichuan University.
- Ambassador for Epilepsy Awardee, awarded jointly by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE).
- Standing Committee Member & Vice Chair, Chinese Neurological Society.
- Commission Member, ILAE Commission on Asian Affairs / Commission on Diagnostic Methods.
- Principal Investigator for landmark national clinical research consortia focusing on epilepsy genomics, refractory status epilepticus treatment algorithms, and post-stroke epileptogenesis.
Clinical Breakthroughs: Redefining Refractory Epilepsy Care
Over 30% of epilepsy patients fail to achieve seizure freedom with standard anti-seizure medications (ASMs). Prof. Zhou established West China Hospital's Comprehensive Epilepsy Center as an international benchmark institution, pioneering integrated diagnostics and minimally invasive curative therapies.
Key Neurological Innovations Led by Prof. Dong Zhou:
- High-Precision SEEG Epileptogenic Zone Localization: Developed robotic-guided stereoelectroencephalography (SEEG) recording frameworks combined with high-density fMRI and PET-MRI coregistration, enabling three-dimensional mapping of deep-seated, non-lesional, and MRI-negative epileptogenic zones.
- Neuropharmacogenomics & Severe Cutaneous Adverse Reaction Prevention: Led pivotal studies demonstrating the critical importance of HLA-B*1502 genetic screening before prescribing carbamazepine and related aromatic anti-seizure medications, effectively eliminating life-threatening Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis in susceptible populations.
- Refractory Epilepsy Neuromodulation Protocols: Established evidence-based clinical algorithms for Vagus Nerve Stimulation (VNS), Deep Brain Stimulation (DBS) of the anterior nucleus of the thalamus, and Responsive Neurostimulation (RNS) for non-resectable or eloquent-cortex seizure foci.
- Diagnostic Triage for Autoimmune & Paraneoplastic Encephalitis: Formulated rapid antibody identification pathways and early immunotherapy protocols for acute new-onset refractory status epilepticus (NORSE) and autoimmune seizure syndromes.
Comprehensive Neurological Scope & Clinical Focus
- Drug-Resistant Epilepsy (DRE): Pre-surgical evaluation for temporal and extratemporal lobe epilepsy, hypothalamic hamartomas, cortical dysplasia, and tuberous sclerosis complex (TSC).
- Intractable Status Epilepticus: Continuous neuro-ICU electroencephalographic monitoring, burst suppression protocols, and neuroprotective management for status epilepticus.
- Cerebrovascular & Small Vessel Diseases: Acute ischemic stroke prevention, intracranial atherosclerosis, cerebral amyloid angiopathy (CAA), CADASIL, and vascular cognitive impairment.
- Neuroimmunology & Autoimmune Encephalopathy: Anti-NMDAR, anti-LGI1, and CASPR2 antibody-associated encephalitis presenting with psychiatric symptoms and seizures.
- Neurogenetic & Rare Seizure Syndromes: Dravet syndrome, progressive myoclonus epilepsies, and mitochondrial encephalopathies diagnosed via whole-exome sequencing and targeted panel analytics.
Benchmark Clinical Scenarios
Scenario A: MRI-Negative Drug-Resistant Epilepsy Cured via SEEG-Guided RF Thermocoagulation
A 26-year-old software architect suffered from daily focal impaired awareness seizures despite maximal doses of four anti-seizure medications. High-field 3T brain MRI was unremarkable. Prof. Zhou organized a comprehensive presurgical workup utilizing multimodal PET-MRI fusion, magnetoencephalography (MEG), and bilateral robotic SEEG electrode placement. A focal focal cortical dysplasia (FCD Type II) in the deep bottom of the left insular sulcus was pinpointed. Under SEEG guidance, precision radiofrequency thermocoagulation (SEEG-RF-TC) was performed through the existing electrode contacts without requiring craniotomy. The patient achieved complete seizure freedom (Engel Class Ia) with normal cognitive and language preservation at two-year follow-up.
Scenario B: Multi-Drug Resistant Temporal Lobe Seizures in an Adolescent
A 15-year-old student with medically refractory temporal lobe epilepsy and severe memory deterioration. Prof. Zhou led a multidisciplinary evaluation involving neurosurgery and neuropsychology, pinpointing hippocampal sclerosis. Following selective amygdalohippocampectomy, the patient achieved full seizure freedom, allowing successful medication tapering and significant cognitive recovery.
Scientific Impact & Global Contributions
Prof. Dong Zhou has published more than 200 research articles in top-tier medical journals including The Lancet Neurology, Brain, Neurology, Annals of Neurology, and Epilepsia. He has led international epidemiological collaborations investigating the burden of epilepsy in Asia and serves as a regular keynote speaker at World Congress of Neurology (WCN) and International Epilepsy Congress (IEC) conferences.
International Patient Access via CMCS
Cross-border patients experiencing unmanageable seizures, diagnostic uncertainty, or stroke-related neurological deficits can coordinate prioritized diagnostic evaluations with Prof. Dong Zhou's clinical team at West China Hospital through China Medical Concierge – Shanghai (CMCS):
- Remote Video-EEG & Neuroimaging Review: Detailed preliminary review of digital EEG recordings, structural MRI, and medication history prior to international departure.
- Comprehensive Inpatient Epilepsy Monitoring Unit (EMU): Expedited admission for 24-to-72-hour long-term video-EEG monitoring with medication withdrawal protocols in dedicated seizure monitoring suites.
- Advanced Presurgical Mapping Coordination: Seamless access to high-resolution 3T MRI with dedicated epilepsy sequences, functional MRI, PET-CT, and SEEG surgical planning.
- Bilingual Clinical Case Management: Dedicated medical accompaniment, translation of clinical consultation reports, medication adjustments, and personalized seizure action plans.
- Post-Discharge Cross-Border Tele-Neurology: Continuous digital follow-up, ASM therapeutic drug monitoring, and coordination with local physicians.
Connect with CMCS Medical Concierge
For confidential clinical inquiries, epilepsy case reviews, or to schedule an evaluation with Prof. Dong Zhou:
Email: contract@medicalsh.com
WhatsApp: Connect on WhatsApp
Official Website: www.medicalsh.com
0 則留言